Making Medicines Affordable A National Imperative (2018) / Chapter Skim
Currently Skimming:
Appendix D: Stakeholder Input
Appendix D: Stakeholder Input
Pages 189-190
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 189... ...
, American College of Physicians GWEN DARIEN, National Patient Advocate Foundation JOSEPH DIMASI, Tufts Center for the Study of Drug Development AUTUMN EHNOW, Medicines360 MARIA FREIRE, Foundation for the National Institutes of Health; United Nations High-Level Panel on Access to Medicines STEVEN GALSON, Amgen ROBERT GALVIN, Equity Healthcare, Blackstone Group JEREMY GREENE, Johns Hopkins University School of Medicine KEVIN GRIMES, Stanford School of Medicine RONALD HANSEN, University of Rochester Simon Business School AARON KESSELHEIM, Brigham and Women's Hospital CHRISTOPHER KOLLER (Co-Sponsor) , Milbank Memorial Fund SHARON LEVINE, Kaiser Permanente Medical Group FREDA LEWIS-HALL, Pfizer Inc.
|
From page 190... ...
CHRISTOPHER VIEHBACHER, Boston Pharmaceuticals; formerly, Sanofi HAIME WORKIE, Financial Industry Regulatory Authority
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.